Executive Capital
Optimize your team's performance with Advantary's full suite of Executive Capital recruiting services delivered by an outstanding team of 30+ industry-experienced recruiters and HR advisors.
Executive Capital Overview
Whether you’re a CEO of a late-stage startup or a founder putting together your management team for the first time, you are sure to face challenges with HR issues, executive team cohesion, or organizational growth pains.
​
Don’t struggle alone. Get the strategic guidance you need from Advantary’s Executive Capital services who can help you avoid disruption by “people issues.” We’ll help you find an HR advisor or a team of experts who can help you hire and develop the right talent to grow your business.
Here's a deck describing our Executive Capital Practice in more detail.
Executive Capital Services
Leadership Team Assessments and Coaching
-
Map functional leadership and scaling capabilities of your global management team
-
Identify gaps and issues, with recommendations on coaching/replacement/additions to the team
-
Assess board composition, effectiveness, and dynamics
​
Executive and Board Search
-
Hire for C-level and VP levels across all functions
-
Achieve diversity on your executive team and board for best performance and insight
​
Organizational Consulting
-
Assess your company’s culture and people practices
-
Build an inclusive, productive company culture through innovative and effective DEI consulting​​
CEO Fractional and Advisory Consultants
-
Advisory Chief People Officer: Team with a confidential HR practitioner expert who can provide objective advice for organizational issues that arise as your company evolves
-
Advisory Diversity Officer: Gain access to a fractional DEI leader for wherever your company is on its DEI journey
​
Click here to discuss your recruiting and executive coaching needs.
​
Alan Cullen has been in executive search for more than a quarter century. He founded Westwood & Wilshire in 2003 and quickly established the firm as a premier boutique search firm in the biotechnology and pharmaceutical industries. In the last decade, he has led the firm's shift towards innovative growth companies at the forefront of science, medicine and technology.